Distalmotion has been granted De Novo approval by the U.S. Food and Drug Administration (FDA) to market the Dexter Surgical Robot for adult inguinal hernia repair.
Advanced AI-driven therapies transform the landscape of brain health and neurodevelopmental treatment. Cosmos Healthcare, a leader in innovative health solutions, is proud to launch two groundbreaking advancements in brain analysis and therapy: Neuromap® and the QPAN Model.
Researchers from Cornell University and the Cleveland Clinic have developed an open-access web database and software to facilitate the discovery of critical protein-protein interactions that can be targeted with medications.
A team of engineers from the University of Houston has published a study in Nature examining the role of international air travel in the global spread of COVID-19. Using a newly developed AI tool, the researchers identified infection hotspots linked to air traffic, pinpointing key areas that significantly contribute to disease transmission.
AI shows considerable potential for medical diagnosis through imaging data, though it often struggles with rare diseases due to limited training data. Professor Klaus-Robert Müller’s team at TU Berlin/BIFOLD, in collaboration with Charité – Universitätsmedizin Berlin, has introduced a new approach to address this challenge by training an AI model on common findings to improve the detection of rare diseases.
A group of scientists from Nanyang Technological University have developed grain-sized soft robots that can be guided by magnetic fields for targeted drug delivery. Published in the journal Advanced Materials, the study presents the first documented example of tiny robots capable of carrying up to four distinct medications and releasing them in controlled doses and sequences.
AI Word Wiz Corp, renowned for its groundbreaking applications of artificial intelligence in medicine, unveils Womb Watch AI, a game-changer in the realm of maternal healthcare.
A new interim analysis from Ovation Fertility and Alife Health is exploring the potential of artificial intelligence (AI) to improve embryo selection during in vitro fertilization (IVF) procedures.
Researchers from the University of Washington Medicine have developed the first wearable camera system that uses artificial intelligence (AI) to detect potential medication delivery errors. Their findings were published in npj Digital Medicine on October 22, 2024.
Anitoa Systems, LLC., a Silicon Valley biotechnology company and market leader in rapid, portable molecular testing, today announced the launch of a computer vision guided collaborative robot (Cobot) system for automating qPCR sample preparation.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.